Cargando…
Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis
Human African trypanosomiasis (HAT), or sleeping sickness, results from infection with the protozoan parasites Trypanosoma brucei (T.b.) gambiense or T.b.rhodesiense and is invariably fatal if untreated. There are 60 million people at risk from the disease throughout sub-Saharan Africa. The infectio...
Autores principales: | Rodgers, Jean, Jones, Amy, Gibaud, Stéphane, Bradley, Barbara, McCabe, Christopher, Barrett, Michael P., Gettinby, George, Kennedy, Peter G. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167784/ https://www.ncbi.nlm.nih.gov/pubmed/21909447 http://dx.doi.org/10.1371/journal.pntd.0001308 |
Ejemplares similares
-
Magnetic Resonance Imaging to Assess Blood–Brain Barrier Damage in Murine Trypanosomiasis
por: Rodgers, Jean, et al.
Publicado: (2011) -
Trypanosomiasis Relapse after Melarsoprol Therapy, Democratic Republic of Congo, 1982–2001
por: Pépin, Jacques, et al.
Publicado: (2005) -
Generation of neuroinflammation in human African trypanosomiasis
por: Rodgers, Jean, et al.
Publicado: (2019) -
Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis
por: Kennedy, Peter G. E., et al.
Publicado: (2019) -
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis
por: Rodgers, Jean, et al.
Publicado: (2009)